Anti-Amyloid Monoclonal Antibodies are Transformative Treatments that Redefine Alzheimer's Disease Therapeutics Jeffrey Cummings Current Opinion Open access 15 April 2023 Pages: 569 - 576
Novel Drugs for the Treatment of Pulmonary Arterial Hypertension: Where Are We Going? Ayedh K. AlamriChristy L. MaJohn J. Ryan Leading Article 05 April 2023 Pages: 577 - 585
The Comparative Effectiveness and Safety of Insomnia Drugs: A Systematic Review and Network Meta-Analysis of 153 Randomized Trials Bei PanLong GeKehu Yang Systematic Review 22 March 2023 Pages: 587 - 619
Recent Human Papillomavirus Vaccination is Associated with a Lower Risk of COVID-19: A US Database Cohort Study Thomas Yen-Ting ChenShiow-Ing WangJames Cheng-Chung Wei Original Research Article 10 May 2023 Pages: 621 - 632
Efanesoctocog Alfa: First Approval Susan J. Keam AdisInsight Report Open access 06 April 2023 Pages: 633 - 638
Keverprazan Hydrochloride: First Approval Connie Kang AdisInsight Report 19 April 2023 Pages: 639 - 643
Comment on: ‘Should We Interfere with the Interleukin-6 Receptor During COVID-19: What Do We Know?’ Chia Siang KowDinesh Sangarran RamachandramSyed Shahzad Hasan Letter to the Editor 04 May 2023 Pages: 645 - 646
Authors’ Reply to Chia Siang Kow et al.: Comment on: ‘Should We Interfere with the Interleukin-6 Receptor During COVID-19: What Do We Know So Far?’ Alexia PlocqueFrancois Philippart Letter to the Editor 04 May 2023 Pages: 647 - 648
